|
C11ORF30 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.62458935193399E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.11022302462516E-16 |
| Stage1-vs-Stage2 |
5.685400E-01 |
| Stage1-vs-Stage3 |
1.840660E-03 |
| Stage1-vs-Stage4 |
1.579170E-04 |
| Stage2-vs-Stage3 |
9.593900E-02 |
| Stage2-vs-Stage4 |
1.897780E-02 |
| Stage3-vs-Stage4 |
4.257200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.43030032262459E-10 |
| Normal-vs-Asian |
1.33226762955019E-15 |
| Caucasian-vs-AfricanAmerican |
5.153200E-01 |
| Caucasian-vs-Asian |
3.321200E-01 |
| AfricanAmerican-vs-Asian |
9.479400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
9.597700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.00419999982115E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.595700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.205510E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.648100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.396000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.224400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.588200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.84789999999802E-05 |
| Classical-VS-Follicular |
5.830800E-01 |
| Classical-VS-Other |
5.624000E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
3.058900E-03 |
| Tall-VS-Other |
1.780990E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.593600E-01 |
| Follicular-VS-Normal |
1.62447832963153E-12 |
| Other-VS-Normal |
1.81066999999091E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.193000E-01 |
|
|
